Synapse - Carlyn Rose Tan

Results (144)

Real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals: An analysis using the Premier Healthcare Database

Journal Article

Tan, C. R.; Chinaeke, E.; Kim, N.; Lin, D.; Hester, L.; Fowler, J.; Gifkins, D.; Walker, S.; Fu, A. Z.; Wu, B.
Journal of Managed Care & Specialty Pharmacy (2025)

Fulltext@MSK | Save

Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience

Journal Article

Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
Blood Neoplasia (2025)

Fulltext@MSK | Save

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

Correspondence

Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
Blood Cancer Journal (2025)

Fulltext@MSK | Save

Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing

Research Letter

Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
Blood Advances (2025)

Fulltext@MSK | Save

Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: An International Myeloma Foundation immunotherapy database real-world analysis: IMMUNOTHERAPY

Correspondence

Mian, H.; Martin, T. G.; Pond, G. R.; Asoori, S.; Popat, R.; Kastritis, E.; Martinez-Lopez, J.; Abdallah, N.; Chhabra, S.; Parrondo, R.; more...
Leukemia (2025)

Fulltext@MSK | Save

Real-world evidence evaluating teclistamab in patients with relapsed/refractory multiple myeloma: A systematic literature review

Review

Derman, B.; Tan, C.; Steinfield, I.; Wilson, F. R.; Lin, D.; Wu, B.; Fernandez, M.; Fowler, J.; Paner-Straseviciute, A.; Kim, N.; more...
Cancers (2025)

Fulltext@MSK | Save

Perspectives on talquetamab and its utility in the treatment of multiple myeloma: Safety, efficacy and place in therapy

Review

Miller, K. C.; Hamadeh, I.; Tan, C. R.
Cancer Management and Research (2025)

Fulltext@MSK | Save

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): An International Myeloma Working Group Study

Journal Article

Tan, C. R.; Asoori, S.; Huang, C. Y.; Brunaldi, L.; Popat, R.; Kastritis, E.; Martinez-Lopez, J.; Bansal, R.; Silva Corraes, A. D. M.; Chhabra, S.; more...
Blood Cancer Journal (2025)

Fulltext@MSK | Save

Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis

Journal Article

Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Evaluating serum free light chain ratio as a biomarker in multiple myeloma

Journal Article

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
Haematologica (2025)

Fulltext@MSK | Save